American Healthcare REIT, Inc. (AHR) P/E Ratio History
Fairly ValuedTrading at 126.2x, near 5Y avg of 144.3x · 75th percentile · In line with own history · Data 2025–2026
Loading P/E history...
P/E Ratio Analysis
As of October 24, 2026, American Healthcare REIT, Inc. (AHR) trades at a price-to-earnings ratio of 126.2x, with a stock price of $53.02 and trailing twelve-month earnings per share of $0.63.
The current P/E is 13% below its 5-year average of 144.3x. Over the past five years, AHR's P/E has ranged from a low of 76.6x to a high of 304.2x, placing the current valuation at the 75th percentile of its historical range.
Compared to the Real Estate sector median P/E of 22.5x, AHR trades at a 461% premium to its sector peers. The sector includes 175 companies with P/E ratios ranging from 0.0x to 197.7x.
The PEG ratio of 1.89 (P/E divided by 245% EPS growth) suggests a fair valuation relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.
Relative to the broader market, AHR commands a significant premium over the S&P 500 median P/E of 26.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our AHR DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
AHR Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
AHR P/E vs Peers
Diversified healthcare real estate peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $171B | 170.7 | - | -11% | |
| $42B | 160.7 | - | +184%Best | |
| $13B | 192.5 | - | -72% | |
| $14B | 23.8 | 1.02Best | +25% | |
| $5B | 30.6 | - | +19% | |
| $2B | 17.4Lowest | - | +24% | |
| $9B | 23.3 | 1.10 | +96% | |
| $3B | 22.2 | - | -4% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
AHR Historical P/E Data (2025–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q2 | - | $52.15 | $0.68 | 76.6x | -47% |
| FY2026 Q1 | - | $47.16 | $0.58 | 81.0x | -44% |
| FY2025 Q4 | Dec 31 2025 | $47.06 | $0.41 | 115.2x | -20% |
| FY2025 Q3 | - | $42.01 | $0.14 | 304.2x | +111% |
Average P/E for displayed period: 144.3x
AHR Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
1+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
AHR — Frequently Asked Questions
Quick answers to the most common questions about buying AHR stock.
What is AHR's P/E ratio?
American Healthcare REIT, Inc. (AHR) trailing twelve-month P/E ratio is 126.2x, based on TTM diluted EPS of $0.63. The 5-year average P/E is 144.3x and the historical range spans 76.6x to 304.2x.
Is AHR stock overvalued or undervalued?
AHR trades at 126.2x P/E, near its 5-year average of 144.3x. The 75th percentile ranking within the 76.6x–304.2x historical range places valuation within normal bounds.
Is AHR stock expensive?
AHR is fairly valued relative to its own history. The current P/E of 126.2x is near the 5-year average of 144.3x (75th percentile of historical range).
What is AHR's historical P/E range?
Over the past 5 years, AHR's P/E ratio has ranged from 76.6x to 304.2x, with a median of 115.2x and an average of 144.3x. The current P/E of 126.2x places the stock at the 75th percentile of this range. Full historical data spans 2025–2026.
How does AHR's P/E compare to the S&P 500?
AHR trades at 126.2x P/E versus the S&P 500 median of 26.2x. The 382% premium to the market typically reflects higher expected earnings growth or quality.
How does AHR's valuation compare to Real Estate peers?
American Healthcare REIT, Inc. P/E of 126.2x compares to the Real Estate sector median of 22.5x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is AHR's PEG ratio?
AHR PEG ratio is 1.89, based on a P/E of 126.2x and EPS growth of 244.8%. A PEG between 1 and 2 suggests valuation aligns with growth expectations — typically considered fair.
What is AHR's earnings yield?
AHR earnings yield is 0.79%, the inverse of its 126.2x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.